CoChat
Sign Up
Cited by 287

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Involvement of mast cells in eosinophilic esophagitis

Abonia, J. Pablo, Blanchard, Carine, Butz, Bridget Buckmeier, Rainey, Heather F., Collins, Margaret H., Stringer, Keith, Putnam, Philip E., Rothenberg, Marc E.·2010·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2010.04.009PMC PMC2902643
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2010.04.009

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 60

  1. Noel, 2004, Eosinophilic esophagitis, N Engl J Med, 351, 940, 10.1056/NEJM200408263510924 · DOI
  2. Gill, 2007, Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004), Am J Gastroenterol, 102, 2281, 10.1111/j.1572-0241.2007.01352.x · DOI
  3. Straumann, 2005, Eosinophilic esophagitis: escalating epidemiology?, J Allergy Clin Immunol, 115, 418, 10.1016/j.jaci.2004.11.006 · DOI
  4. Kelly, 1995, Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula, Gastroenterology, 109, 1503, 10.1016/0016-5085(95)90637-1 · DOI
  5. Walsh, 1999, Allergic esophagitis in children: a clinicopathological entity, Am J Surg Pathol, 23, 390, 10.1097/00000478-199904000-00003 · DOI
  6. Rothenberg, 2004, Eosinophilic gastrointestinal disorders (EGID), J Allergy Clin Immunol, 113, 11, 10.1016/j.jaci.2003.10.047 · DOI
  7. Collins, 2008, Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases, Clin Gastroenterol Hepatol, 6, 621, 10.1016/j.cgh.2008.01.004 · DOI
  8. Sant'Anna, 2004, Eosinophilic esophagitis in children: symptoms, histology and pH probe results, J Pediatr Gastroenterol Nutr, 39, 373, 10.1002/j.1536-4801.2004.tb00869.x · DOI
  9. Lim, 2004, White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children, Gastrointest Endosc, 59, 835, 10.1016/S0016-5107(04)00364-5 · DOI
  10. Jyonouchi, 2009, Association of eosinophilic gastrointestinal disorders with other atopic disorders, Immunol Allergy Clin North Am, 29, 85, 10.1016/j.iac.2008.09.008 · DOI
  11. Spergel, 2007, Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis, J Allergy Clin Immunol, 119, 509, 10.1016/j.jaci.2006.11.016 · DOI
  12. Kagalwalla, 2006, Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis, Clin Gastroenterol Hepatol, 4, 1097, 10.1016/j.cgh.2006.05.026 · DOI
  13. Mishra, 2001, An etiological role for aeroallergens and eosinophils in experimental esophagitis, J Clin Invest, 107, 83, 10.1172/JCI10224 · DOI
  14. Mishra, 2002, IL-5 promotes eosinophil trafficking to the esophagus, J Immunol, 168, 2464, 10.4049/jimmunol.168.5.2464 · DOI
  15. Simon, 2005, Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases, J Allergy Clin Immunol, 115, 1090, 10.1016/j.jaci.2005.01.017 · DOI
  16. Straumann, 2003, Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years, Gastroenterology, 125, 1660, 10.1053/j.gastro.2003.09.024 · DOI
  17. Straumann, 2001, Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response, J Allergy Clin Immunol, 108, 954, 10.1067/mai.2001.119917 · DOI
  18. Blanchard, 2006, Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis, J Clin Invest, 116, 536, 10.1172/JCI26679 · DOI
  19. Blanchard, 2006, Eosinophilic esophagitis: pathogenesis, genetics, and therapy, J Allergy Clin Immunol, 118, 1054, 10.1016/j.jaci.2006.07.038 · DOI
  20. Blanchard, 2007, IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids, J Allergy Clin Immunol, 120, 1292, 10.1016/j.jaci.2007.10.024 · DOI
  21. Prussin, 2009, Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses, J Allergy Clin Immunol, 124, 1326, 10.1016/j.jaci.2009.09.048 · DOI
  22. Rothenberg, 2010, Common variants at 5q22 associate with pediatric eosinophilic esophagitis, Nat Genet, 42, 289, 10.1038/ng.547 · DOI
  23. Aceves, 2007, Esophageal remodeling in pediatric eosinophilic esophagitis, J Allergy Clin Immunol, 119, 206, 10.1016/j.jaci.2006.10.016 · DOI
  24. Chehade, 2007, Esophageal subepithelial fibrosis in children with eosinophilic esophagitis, J Pediatr Gastroenterol Nutr, 45, 319, 10.1097/MPG.0b013e31806ab384 · DOI
  25. Konikoff, 2006, A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis, Gastroenterology, 131, 1381, 10.1053/j.gastro.2006.08.033 · DOI
  26. Kirsch, 2007, Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease, J Pediatr Gastroenterol Nutr, 44, 20, 10.1097/MPG.0b013e31802c0d06 · DOI
  27. Ruchelli, 1999, Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy, Pediatr Dev Pathol, 2, 15, 10.1007/s100249900084 · DOI
  28. Leder, 1979, The chloroacetate esterase reaction. A useful means of histological diagnosis of hematological disorders from paraffin sections of skin, Am J Dermatopathol, 1, 39, 10.1097/00000372-197901010-00005 · DOI
  29. Beckstead, 1981, Enzyme histochemistry and immunohistochemistry on biopsy specimens of pathologic human bone marrow, Blood, 57, 1088, 10.1182/blood.V57.6.1088.1088 · DOI
  30. Friend, 2000, Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection, J Immunol, 165, 344, 10.4049/jimmunol.165.1.344 · DOI
  31. Zimmermann, 2003, Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis, J Clin Invest, 111, 1863, 10.1172/JCI17912 · DOI
  32. Hosack, 2003, Identifying biological themes within lists of genes with EASE, Genome Biol, 4, R70, 10.1186/gb-2003-4-10-r70 · DOI
  33. Vicario, 2010, Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis, Gut, 59, 12, 10.1136/gut.2009.178020 · DOI
  34. Aceves, 2007, Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder, J Clin Gastroenterol, 41, 252, 10.1097/01.mcg.0000212639.52359.f1 · DOI
  35. Spergel, 2005, Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests, Ann Allergy Asthma Immunol, 95, 336, 10.1016/S1081-1206(10)61151-9 · DOI
  36. Geissler, 1991, Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter, Somat Cell Mol Genet, 17, 207, 10.1007/BF01232978 · DOI
  37. Miller, 1990, Cloning and characterization of a second complementary DNA for human tryptase, J Clin Invest, 86, 864, 10.1172/JCI114786 · DOI
  38. Sheth, 2003, Inhibition of dipeptidyl peptidase I in the human mast cell line HMC-1: blocked activation of tryptase, but not of the predominant chymotryptic activity, Biochem Pharmacol, 66, 2251, 10.1016/j.bcp.2003.08.002 · DOI
  39. Reynolds, 1989, Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases, Proc Natl Acad Sci U S A, 86, 9480, 10.1073/pnas.86.23.9480 · DOI
  40. Abonia, 2005, Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2, Blood, 105, 4308, 10.1182/blood-2004-09-3578 · DOI
  41. Murakami, 1992, Characteristics and possible functions of mast cell phospholipases A2, Adv Exp Med Biol, 318, 27, 10.1007/978-1-4615-3426-6_3 · DOI
  42. Ludowyke, 2000, Transient translocation and activation of protein phosphatase 2A during mast cell secretion, J Biol Chem, 275, 6144, 10.1074/jbc.275.9.6144 · DOI
  43. Caughey, 2000, Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families, J Immunol, 164, 6566, 10.4049/jimmunol.164.12.6566 · DOI
  44. Urata, 1991, Cloning of the gene and cDNA for human heart chymase, J Biol Chem, 266, 17173, 10.1016/S0021-9258(19)47355-9 · DOI
  45. Caughey, 1991, Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase, J Biol Chem, 266, 12956, 10.1016/S0021-9258(18)98788-0 · DOI
  46. Wong, 1999, Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension, J Biol Chem, 274, 30784, 10.1074/jbc.274.43.30784 · DOI
  47. Costa, 1996, Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo, J Exp Med, 183, 2681, 10.1084/jem.183.6.2681 · DOI · Paper page
  48. Bischoff, 1992, c-kit ligand: a unique potentiator of mediator release by human lung mast cells, J Exp Med, 175, 237, 10.1084/jem.175.1.237 · DOI
  49. Columbo, 1992, The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils, J Immunol, 149, 599, 10.4049/jimmunol.149.2.599 · DOI
  50. Wershil, 1992, The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function, J Exp Med, 175, 245, 10.1084/jem.175.1.245 · DOI
  51. Hammerberg, 2001, Skin mast cell histamine release following stem cell factor and high-affinity immunoglobulin E receptor cross-linking in dogs with atopic dermatitis, Vet Dermatol, 12, 339, 10.1046/j.0959-4493.2001.00273.x · DOI
  52. Feldweg, 2003, gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo, Eur J Immunol, 33, 2262, 10.1002/eji.200323978 · DOI
  53. Sakai, 1996, A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I, J Clin Invest, 97, 988, 10.1172/JCI118523 · DOI
  54. Lucendo, 2007, Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus, Am J Surg Pathol, 31, 598, 10.1097/01.pas.0000213392.49698.8c · DOI
  55. Lucendo, 2009, The role of mast cells in eosinophilic esophagitis, Pediatr Allergy Immunol, 20, 512, 10.1111/j.1399-3038.2008.00798.x · DOI
  56. Pejler, 2009, Novel insights into the biological function of mast cell carboxypeptidase A, Trends Immunol, 30, 401, 10.1016/j.it.2009.04.008 · DOI
  57. Wallin, 1999, The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma, Am J Respir Crit Care Med, 159, 79, 10.1164/ajrccm.159.1.9801007 · DOI
  58. Wallin, 2003, Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma, J Allergy Clin Immunol, 112, 72, 10.1067/mai.2003.1518 · DOI
  59. Stein, 2006, Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis, J Allergy Clin Immunol, 118, 1312, 10.1016/j.jaci.2006.09.007 · DOI
  60. Straumann, 2010, Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial, Gut, 59, 21, 10.1136/gut.2009.178558 · DOI

Cited by

Sorted by citations

Metadata

Authors
Abonia, J. P., Blanchard, C., Butz, B. B., Rainey, H. F., Collins, M. H., Stringer, K., Putnam, P. E., & Rothenberg, M. E.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2010-07
Volume
126
Issue
1
Pages
140-149
ISSN
0091-6749
DOI
10.1016/j.jaci.2010.04.009
PMC
PMC2902643
Cited by
287
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review